NL-OMON20429尚未招募不适用
Bosentan in exercise induced pulmonary arterial hypertension in congenital heart disease.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •1. Adult (>18 years) and mentally competent;
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •1. Incapable of giving informed consent;
研究者
相似试验
已完成
2 期
Bosentan in Exercise Induced Pulmonary Arterial Hypertension in Congenital Heart DiseaseExercise induced pulmonary arterial hypertensionincreased pulmonary pressure during exercise1001039410057166NL-OMON40031Academisch Medisch Centrum40
终止
4 期
Effects of Bosentan on Respiratory MechanicsPulmonary HypertensionNCT00679068IRCCS Azienda Ospedaliero-Universitaria di Bologna4
已完成
1 期
Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by HypoxiaHypoxia-Induced Pulmonary Artery HypertensionNCT00260819Assistance Publique - Hôpitaux de Paris20
Unknown
1 期
Bosentan for Severe Mitral Valve DysfunctionSECONDARY PULMONARY HYPERTENSIONCHILDHOOD RHEUMATOID FEVERCONGESTIVE HEART FAILUREMITRAL STENOSISNCT01270750General Hospital of Chalkida10
进行中（未招募）
1 期
BOsentan for Mild Pulmonary vascular disease in Asd patients (the BOMPA trial): a double-blind, randomized controlled, pilot trial - BOMPA trialEUCTR2010-020209-33-BEniversity Hospitals Leuven20